Mark J Bolland Andrew Grey Anne M Horne Mark G Thomas
10.1186/1476-0711-7-3
Ann Clin Microbiol Antimicrob
2008 Jan 28;7:3.
CC BY
https://pubmed.ncbi.nlm.nih.gov/18226256/
Anti-Bacterial Agents / adverse effects Cytochrome P-450 Enzyme System / metabolism HIV Infections / complications Mycobacterium avium-intracellulare Infection / drug therapy Osteomalacia / etiology Rifabutin / adverse effects
Anti-Bacterial Agents / adverse effects Cytochrome P-450 Enzyme System / metabolism HIV Infections / complications Mycobacterium avium-intracellulare Infection / drug therapy Osteomalacia / etiology Rifabutin / adverse effects Case Reports AIDS-Related Opportunistic Infections / drug therapy Alkaline Phosphatase / analysis Anti-Bacterial Agents / metabolism Anti-Bacterial Agents / therapeutic use Bone Density HIV Infections / drug therapy Humans Hyperparathyroidism, Secondary / etiology Male Middle Aged Mycobacterium avium-intracellulare Infection / diagnosis Osteomalacia / chemically induced Osteomalacia / drug therapy Rifabutin / metabolism Rifabutin / therapeutic use Vitamin D Deficiency / chemically induced Vitamin D Deficiency / drug therapy Vitamin D Deficiency / etiology Anti-Bacterial Agents Rifabutin Cytochrome P-450 Enzyme System Alkaline Phosphatase
PMC2253556
18226256
Osteomalacia in an HIV-infected man receiving rifabutin, a cytochrome P450 enzyme inducer: a case report
2008